Diana Roettger, PhD, and Olga Kubassova, PhD[email protected]MRIAdvanced imaging offers insight into targeted therapiesMajor breakthroughs are emerging in the development of targeted therapies that use the body's own immune system to attack cancer cells. But traditional methods of measuring the success of drug candidates are slow and expensive. Could advanced imaging help? Diana Roettger, PhD, and Olga Kubassova, PhD, of the Image Analysis Group offer a perspective.February 5, 2019Page 1 of 1Top StoriesCTLDCT predicts vertebral fracture risk in heavy smokersParticipants were heavy smokers aged 55 to 74 years old with at least 30 pack-years of smoking history.Digital X-RayChatGPT-5 misses half of distal radius fractures on x-raysAISIIM-CAIMI: AI triaging for ICH leads to faster turnaround timesMRISIIM-CAIMI: 20% of advanced imaging prior auth denials get overturnedSponsor ContentFREE webinar: find your imaging capacity